J Drugs Dermatol. 2024 Sep 1;23(9):729-734. doi: 10.36849/JDD.8057.
Poly-L-lactic acid (PLLA) is an injectable filler used for restoring facial fat volume loss that improves skin quality.
To evaluate the histological changes underlying the observed improvement in skin quality after repeated PLLA injections.
Ten healthy women were enrolled in this randomized, placebo-controlled, single-center study. Eligible subjects received 3 treatments every 4 weeks with either PLLA (treatment group) or saline (control group) injections, into both sides of the face. Follow-up visits were at week 18 after the last treatment. Assessments included live ratings, patient questionnaires, three-dimensional microtopography imaging analysis, and histological analysis from biopsies taken before and after PLLA treatment.
At the 18-week follow-up, there was a significant improvement in investigator- and subject-rated global aesthetic improvement (GAIS) scores, as well as a decrease in wrinkle severity in PLLA-treated but not placebo-treated patients. Skin quality parameters of erythema, pore size, and roughness were significantly improved from baseline and compared with placebo at the 18-week follow-up as assessed by microtopographic analysis and investigator ratings. Histologic analysis revealed increased tissue remodeling and angiogenesis in PLLA-treated tissues at the 18-week follow-up and decreased elastin fragmentation compared with baseline. No treatment-related adverse events occurred.
Repeated PLLA treatments may improve skin quality through tissue remodeling and neovascularization. J Drugs Dermatol. 2024;23(9):729-734. doi:10.36849/JDD.8057.
聚左旋乳酸(PLLA)是一种可注射填充剂,用于恢复面部脂肪体积丢失,改善皮肤质量。
评估重复 PLLA 注射后皮肤质量改善的组织学变化。
本研究为一项随机、安慰剂对照、单中心研究,共纳入 10 名健康女性。符合条件的受试者每 4 周接受 3 次治疗,分别接受 PLLA(治疗组)或生理盐水(对照组)注射,双侧面部各接受一次。末次治疗后 18 周进行随访。评估包括现场评分、患者问卷调查、三维微地形成像分析和 PLLA 治疗前后活检的组织学分析。
18 周随访时,研究者和受试者评估的整体美学改善(GAIS)评分均显著改善,且 PLLA 治疗组而非安慰剂治疗组的皱纹严重程度降低。微地形分析和研究者评估显示,皮肤质量参数如红斑、毛孔大小和粗糙度在 18 周随访时均较基线显著改善,并优于安慰剂。
重复 PLLA 治疗可能通过组织重塑和血管生成来改善皮肤质量。J 皮肤病药物杂志。2024;23(9):729-734.doi:10.36849/JDD.8057.